Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection.
BACKGROUND
Host serine proteases are essential for the influenza virus life cycle because the viral haemagglutinin is synthesized as a precursor which requires proteolytic maturation. Therefore, we studied the activity and expression of serine proteases in lungs from mice infected with influenza and evaluated the effect of serine protease inhibitors on virus replication both in cell culture and in infected mice.


RESULTS
Two different inbred mouse strains were investigated: DBA/2J as a highly susceptible and C57Bl/6J as a more resistant strain to influenza virus infection. The serine proteases from lung homogenates of mice exhibited pH optima of 10.00. Using the substrate Bz-Val-Gly-Arg-p-nitroanilide or in zymograms, the intensities of proteolysis increased in homogenates from both mouse strains with time post infection (p.i.) with the mouse-adapted influenza virus A/Puerto Rico/8/34 (H1N1; PR8). In zymograms at day 7 p.i., proteolytic bands were stronger and numerous in lung homogenates from DBA/2J than C57Bl/6J mice. Real-time PCR results confirmed differential expression of several lung proteases before and after infecting mice with the H1N1 virus. The most strongly up-regulated proteases were Gzma, Tmprss4, Elane, Ctrl, Gzmc and Gzmb. Pretreatment of mouse and human lung cell lines with the serine protease inhibitors AEBSF or pAB or a cocktail of both prior to infection with the H1N1 or the A/Seal/Massachusetts/1/80 (H7N7; SC35M) virus resulted in a decrease in virus replication. Pretreatment of C57Bl/6J mice with either AEBSF or a cocktail of AEBSF and pAB prior to infection with the H1N1 virus significantly reduced weight loss and led to a faster recovery of treated versus untreated mice while pAB alone exerted a very poor effect. After infection with the H7N7 virus, the most significant reduction of weight loss was obtained upon pretreatment with either the protease inhibitor cocktail or pAB. Furthermore, pretreatment of C57BL/6J mice with AEBSF prior to infection resulted in a significant reduction in the levels of both the H1N1 and H7N7 nucleoproteins in mice lungs and also a significant reduction in the levels of the HA transcript in the lungs of the H1N1--but not the H7N7-infected mice.


CONCLUSIONS
Multiple serine protease activities might be implicated in mediating influenza infection. Blocking influenza A virus infection in cultured lung epithelia and in mice by the used serine protease inhibitors may provide an alternative approach for treatment of influenza infection.
Department of Infection Genetics and University of Veterinary Medicine Hannover, Helmholtz Centre for Infection Research, Braunschweig, Germany. mbahgatriad@yahoo.com
Mahmoud M
MM
Bahgat
Paulina
P
Błazejewska
Klaus
K
Schughart
D000818:Animals; D001835:Body Weight; D002460:Cell Line; D004847:Epithelial Cells / Q000821:virology; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects / Q000472:pathogenicity*; D053126:Influenza A Virus, H7N7 Subtype / Q000187:drug effects / Q000472:pathogenicity*; D008168:Lung / Q000201:enzymology* / Q000821:virology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D009976:Orthomyxoviridae Infections / Q000188:drug therapy* / Q000517:prevention & control; D057057:Serine Proteases / Q000378:metabolism*; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use*; D014779:Virus Replication / Q000187:drug effects
D015842:Serine Proteinase Inhibitors; D057057:Serine Proteases
Virology. 1992 May;188(1):408-13
1566583
Virology. 1973 Nov;56(1):172-80
4795670
Mol Cell Biol. 1998 Nov;18(11):6387-98
9774654
Am J Respir Crit Care Med. 2005 May 15;171(10):1070-6
15695494
Immunol Cell Biol. 2006 Feb;84(1):79-86
16405655
Bioorg Med Chem. 2009 Nov 1;17(21):7477-86
19811924
Proc Assoc Am Physicians. 1999 Sep-Oct;111(5):390-5
10519158
Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10224-8
9707628
Anal Biochem. 1980 Feb;102(1):196-202
7188842
Am J Respir Crit Care Med. 2000 Jan;161(1):237-43
10619826
Vopr Virusol. 1984 Jul-Aug;29(4):491-7
6208694
PLoS Pathog. 2008 Aug 01;4(8):e1000115
18670648
J Immunol. 2010 Feb 1;184(3):1410-8
20042589
J Biol Chem. 2007 Sep 14;282(37):27424-27435
17627939
J Immunol. 2009 Dec 1;183(11):7441-50
19917678
J Virol. 2009 Oct;83(20):10417-26
19706712
Arch Virol. 1995;140(2):341-8
7710359
J Virol. 2010 Jun;84(11):5605-14
20237084
J Gen Virol. 1984 Jan;65 ( Pt 1):191-6
6198446
Nature. 1987 Feb 5-11;325(6104):536-7
3543690
J Virol. 2006 Oct;80(19):9896-8
16973594
J Virol. 2010 Oct;84(19):10016-25
20631123
J Virol. 2009 Apr;83(7):3200-11
19158246
Virology. 1975 Dec;68(2):440-54
128196
J Virol. 2008 Jul;82(14):6820-8
18448517
Cancer Res. 2001 Feb 15;61(4):1686-92
11245484
Virology. 1975 Dec;68(2):426-39
173078
J Clin Invest. 1983 Aug;72(2):656-66
6603478
Trends Microbiol. 1994 Feb;2(2):39-43
8162439
J Immunol. 2008 Apr 15;180(8):5662-9
18390751
J Helminthol. 2006 Mar;80(1):19-23
16469168
EMBO J. 1992 Jul;11(7):2407-14
1628614
Virology. 1999 May 25;258(1):1-20
10329563
Vaccine. 2009 Oct 23;27(45):6324-9
19840668
Lab Invest. 2009 Nov;89(11):1195-220
19770840
Annu Rev Biochem. 2000;69:531-69
10966468
J Reprod Fertil. 1993 Jan;97(1):173-8
8464008
Antiviral Res. 1994 Feb;23(2):107-18
7511880
Infect Immun. 2007 Jan;75(1):184-92
17043102
FEBS Lett. 1992 Jan 27;296(3):274-8
1537403
J Med Virol. 2010 Dec;82(12):1996-2003
20981785
Microbiol Immunol. 2001;45(10):679-88
11762750
J Gen Virol. 1987 Feb;68 ( Pt 2):425-32
3819696
J Virol. 1990 Jul;64(7):3297-303
2191148
J Virol. 2000 Mar;74(5):2472-6
10666283
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18590-5
16339318
Am J Respir Cell Mol Biol. 1997 Mar;16(3):300-8
9070615
Adv Ther. 2010 Aug;27(8):512-22
20652658
J Virol. 2005 Dec;79(23):14933-44
16282492
Arch Virol. 1996;141(10):1979-89
8920829
PLoS One. 2009;4(3):e4857
19293935
Virus Res. 2001 Sep;77(1):43-9
11451486
Eur J Immunol. 2009 May;39(5):1203-10
19404988
Acta Biol Med Ger. 1972;28(4):577-85
4672611
Curr Pharm Des. 2007;13(4):405-14
17311557
Parasitol Res. 2002 Jun;88(6):495-500
12107470
Clin Exp Immunol. 2003 Sep;133(3):438-47
12930372
Biochem Biophys Res Commun. 1991 Jun 14;177(2):814-20
2049103
Biochemistry. 1989 Mar 7;28(5):1951-63
2655701
Int Arch Allergy Immunol. 1999 Dec;120(4):303-9
10640914
J Infect Dis. 1992 Oct;166(4):783-91
1527412
J Cell Sci. 2006 Dec 15;119(Pt 24):5011-4
17158907
Am Rev Respir Dis. 1985 Aug;132(2):417-33
3896082